<![CDATA[NCKU, National Cheng Kung University - Stories & Perspectives]]> utf-8 2024-06-16 01:51:02 2024-06-16 01:51:02 <![CDATA[Field Testing of National Cheng Kung University's AI Nursing Assistant Earns High Praise from Nurses]]> 2024-06-06 <![CDATA[National Cheng Kung University (NCKU) applied science and technology as diplomacy, and its assistance in investigating benzene concentration in the Hartman Park community, Houston, Texas, USA was recognized]]> 2024-06-05 <![CDATA[Assistant Professor Shu-Han Hsu Becomes One of First Two Recipients from Taiwan to be Honored with Google Research Scholar Award]]> 2024-04-26 <![CDATA[Connecting inspiration, ideas, and impact | NCKU International Brand Film]]> 2023-04-14 <![CDATA[NCKU Carbon Neutral Hub Unveiled: Partnering with Companies to Achieve ESG and Reach Net-Zero Emissions by 2050]]> 2024-05-10 <![CDATA[I-Ching Chen, Associate Professor at National Cheng Kung University, published a study in Nature revealing global mountain climate velocities, highlighting 17 high-risk regions]]> 2024-03-28 <![CDATA[RedBall Project at NCKU Future Venue: Uniting Art and Heritage]]> 2024-04-09 <![CDATA[NCKU Research Team, Led by Prof. Win-Pin Su, Achieves Breakthrough in Lung Cancer Treatment: Published Study on Tumor Microenvironment Remodeling Using Nanotechnology in Prestigious Journal《 Nano Today 》]]> Tumor microenvironment (TME) primarily contributes to resistance in clinical antineoplastic treatment. In non-small-cell lung cancers (NSCLCs), the frequently mutated KRAS oncogene (mainly at the KRASG12C position) promotes tumor progression. The interdisciplinary research team at NCKU has successfully nano-formulated the small-molecular drug Sitravatinib (currently undergoing clinical trials internationally) using polymeric nanoparticles to form the novel nano-drug Au@PSMA-Sit. In the murine lung cancer model bearing KRASG12C mutant TME, Au@PSMA-Sit nanoparticles exhibit outstanding antitumor efficacy, requiring a lower therapeutic dosage (1/10) of sitravatinib. These experimental achievements were published in the authoritative international journal Nano Today in February 2024 with an impact factor of 17.4. Polymeric nano-formulation of spectrum selective RTK inhibitor strengthens anti-cancer effects via immune remodeling by endoplasmic reticulum stress-modulating mitochondrial metabolism ]]> 2024-02-26 <![CDATA[NCKU Takes the Crown Once More in the 2024 Enterprises’ Favorite Survey]]> 2024-02-06 <![CDATA[Selfies of NCKU Lilium-1 From Low Earth Orbit]]> 2024-01-26